Detalhe da pesquisa
1.
Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?
Cancers (Basel)
; 11(12)2019 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31817189